Decreased expression of ligands of placental immune checkpoint inhibitors in uncomplicated and preeclamptic oocyte donation pregnancies

• Published in: Journal of reproductive immunology 2020-11, Vol.142, p.103194-103194, Article 103194
• Main Authors: van 't Hof, L.J., Dijkstra, K.L., van der Keur, C., Eikmans, M., Baelde, H.J., Bos, M., van der Hoorn, M.L.P.
• Format: Article
• Language: English
• Subjects: HLA mismatch; Immune checkpoint inhibition; Maternal-fetal tolerance; Oocyte donation pregnancy; Preeclampsia
• ISSN: 0165-0378; 1872-7603
• DOI: 10.1016/j.jri.2020.103194

•Oocyte donation (OD) pregnancies require enhanced immunoregulation.•The trophoblast uses immune checkpoint inhibition for maternal T cell regulation.•Placental PD-L1 and CD200 expression is lower in uncomplicated and preeclamptic OD pregnancies.•Placental CD200 protein expression and HLA class I mismatches are positively correlated in OD.•Less co-inhibitory signaling might explain the preeclampsia risk in oocyte donation. Oocyte donation (OD) pregnancies are characterized by a complete immunogenetic dissimilarity between mother and fetus, which requires enhanced immunoregulation compared to naturally conceived (NC) pregnancies. The trophoblast expresses co-inhibitory ligands crucial for regulation of the maternal T cell response. Therefore, we studied the role of placental immune checkpoint inhibitors for the establishment of fetal tolerance and their relation to the development of preeclampsia in OD compared to NC pregnancies. Placental tissue from uncomplicated OD (n = 21) and NC (n = 21) pregnancies, and OD (n = 9) and NC (n = 15) pregnancies complicated with preeclampsia were studied. Protein expression of co-inhibitory ligands PD-L1 and CD200 was double blind semi-quantitatively determined by immunohistochemistry. Messenger RNA expression of PD-L1, CD200 and indoleamine 2,3-dioxygenase (IDO) was determined using qPCR. Decreased PD-L1 and CD200 protein expression and increased IDO mRNA expression was observed in uncomplicated OD versus NC pregnancies (all p < 0.05). CD200 protein expression was positively correlated with PD-L1 expression in all groups, with the number of HLA total mismatches and with HLA class I mismatches in uncomplicated OD cases (all p < 0.05). Preeclamptic cases showed lower PD-L1 protein and CD200 protein and mRNA expression in OD compared to NC pregnancies (all p < 0.05). This study shows that signaling by co-inhibitory PD-L1 and CD200 and by immunosuppressive IDO is altered in the placenta of OD pregnancies, suggesting a contribution to the higher risk for preeclampsia. These insights provide future prospects in unraveling the immune paradox of oocyte pregnancy, which are applicable for better risk management and treatment of uncomplicated and preeclamptic pregnancies.